发明公开
- 专利标题： THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY
- 专利标题（中）： 的TLR激动剂及联合用药以治疗用途
-
申请号： EP11830073.0申请日： 2011-10-03
-
公开(公告)号： EP2621500A2公开(公告)日： 2013-08-07
- 发明人: HERSHBERG, Robert , COUKOS, George , DIETSCH, Gregory , FACCIABENE, Andrea , MANJARREZ, Kristi , RANDALL, Tressa, D.
- 申请人： Ventirx Pharmaceuticals, Inc. , The Trustees of the University of Pennsylvania
- 申请人地址： 12651 High Bluff Drive Suite 200 San Diego, CA 92130 US
- 专利权人： Ventirx Pharmaceuticals, Inc.,The Trustees of the University of Pennsylvania
- 当前专利权人： Ventirx Pharmaceuticals, Inc.,The Trustees of the University of Pennsylvania
- 当前专利权人地址： 12651 High Bluff Drive Suite 200 San Diego, CA 92130 US
- 代理机构： Mintz Levin Cohn Ferris Glovsky and Popeo LLP
- 优先权： US390447P 20101006; US388967P 20101001; US388953P 20101001
- 国际公布： WO2012045090 20120405
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; A61K31/122 ; A61K9/127 ; A61K9/48 ; A61P35/00
摘要：
The present invention is directed generally to formulations of a TLR agonist preferably a TLR8 agonist, and its use in the treatment of various diseases, including combination therapies for treating cancer.
公开/授权文献
- EP2621500B1 THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY 公开/授权日：2016-11-23
信息查询
